Skip to main content
Top
Published in: Internal and Emergency Medicine 4/2018

01-06-2018 | IM - CASE RECORD

Abdominal infection reveals a rare disease

Authors: Clara Benedetta Conti, Mirella Fraquelli, Dario Conte

Published in: Internal and Emergency Medicine | Issue 4/2018

Login to get access

Excerpt

A 59-year-old man from Argentina had been well until he came to the Emergency Department (ED) of our hospital presenting with an acute acalculous cholecystitis. The patient was pyretic 38 °C, with mild right-upper abdominal pain (pain scale 5/10) and vomiting. The patient had type-II diabetes and Class-I obesity (BMI 32.7). At physical examination there were no signs of fluid retention, the lactate level was 1.9 mmol/L, and, at abdominal ultrasound (US), the gallbladder showed a thickened edematous wall with increased color-Doppler signals, but no stones or over-distension of the organ were observed. An irregular liver parenchyma with irregular liver profiles and a slightly increased spleen diameter were detected. The portal vein was patent. At blood test, the white blood cell (WBC) count, the C-reactive protein (CRP) and the transaminases were increased. The presence of viral or auto-immune hepatitis was serologically ruled out. …
Literature
1.
go back to reference Northup PG, Caldwell SH (2010) New concepts of coagulation and bleeding in liver disease. Intern Emerg Med 5(1):3–6CrossRefPubMed Northup PG, Caldwell SH (2010) New concepts of coagulation and bleeding in liver disease. Intern Emerg Med 5(1):3–6CrossRefPubMed
2.
go back to reference Senzolo M, Ferronato C, Burra P, Sartori MT (2009) Anticoagulation for portal vein thrombosis in cirrhotic patients should be always considered. Intern Emerg Med 4:161–162CrossRefPubMed Senzolo M, Ferronato C, Burra P, Sartori MT (2009) Anticoagulation for portal vein thrombosis in cirrhotic patients should be always considered. Intern Emerg Med 4:161–162CrossRefPubMed
3.
4.
go back to reference Cazals-Hatem D, Hillaire S, Rudler M, Plessier A, Paradis V, Condat B, Francoz C, Denninger MH, Durand F, Bedossa P, Villa DC (2011) Obliterative portal venopathy: portal hypertension is not always present at diagnosis. J Hepatol 54(3):455–461CrossRefPubMed Cazals-Hatem D, Hillaire S, Rudler M, Plessier A, Paradis V, Condat B, Francoz C, Denninger MH, Durand F, Bedossa P, Villa DC (2011) Obliterative portal venopathy: portal hypertension is not always present at diagnosis. J Hepatol 54(3):455–461CrossRefPubMed
5.
go back to reference Semeraro N, Ammollo CT, Semeraro F, Colucci M (2012) Sepsis, thrombosis and organ dysfunction. Thromb Res 129(3):290–295CrossRefPubMed Semeraro N, Ammollo CT, Semeraro F, Colucci M (2012) Sepsis, thrombosis and organ dysfunction. Thromb Res 129(3):290–295CrossRefPubMed
6.
go back to reference Denninger MH, Chaït Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, Erlinger S, Briere J, Valla D (2000) Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31(3):587–591CrossRefPubMed Denninger MH, Chaït Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, Erlinger S, Briere J, Valla D (2000) Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31(3):587–591CrossRefPubMed
7.
go back to reference Ayala R, Grande S, Bustelos R, Ribera C, García-Sesma A, Jimenez C, Moreno E, Martinez López J (2012) Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients. BMC Gastroenterol 21(12):114CrossRef Ayala R, Grande S, Bustelos R, Ribera C, García-Sesma A, Jimenez C, Moreno E, Martinez López J (2012) Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients. BMC Gastroenterol 21(12):114CrossRef
8.
go back to reference Bureau C, Laurent J, Robic MA, Christol C, Guillaume M, Ruidavets JB, Ferrieres J, Péron JM, Vinel JP (2016) Central obesity is associated with non-cirrhotic portal vein thrombosis. J Hepatol 64(2):427–432CrossRefPubMed Bureau C, Laurent J, Robic MA, Christol C, Guillaume M, Ruidavets JB, Ferrieres J, Péron JM, Vinel JP (2016) Central obesity is associated with non-cirrhotic portal vein thrombosis. J Hepatol 64(2):427–432CrossRefPubMed
9.
go back to reference Raffa S, Reverter JC, Seijo S, Tassies D, Abraldes JG, Bosch J, García-Pagán JC (2012) Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis. Clin Gastroenterol Hepatol 10(1):72–78CrossRefPubMed Raffa S, Reverter JC, Seijo S, Tassies D, Abraldes JG, Bosch J, García-Pagán JC (2012) Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis. Clin Gastroenterol Hepatol 10(1):72–78CrossRefPubMed
10.
go back to reference Yonem Ozlem, Bayraktar Yusuf (2007) Is portal vein cavernous transformation a component of congenital hepatic fibrosis? World J Gastroenterol 13(13):1928–1929CrossRefPubMedPubMedCentral Yonem Ozlem, Bayraktar Yusuf (2007) Is portal vein cavernous transformation a component of congenital hepatic fibrosis? World J Gastroenterol 13(13):1928–1929CrossRefPubMedPubMedCentral
11.
go back to reference Mehta G, Gustot T, Mookerjee RP, Garcia-Pagan JC, Fallon MB, Shah VH, Moreau R, Jalan R (2014) Inflammation and portal hypertension—the undiscovered country. J Hepatol 61(1):155–163CrossRefPubMed Mehta G, Gustot T, Mookerjee RP, Garcia-Pagan JC, Fallon MB, Shah VH, Moreau R, Jalan R (2014) Inflammation and portal hypertension—the undiscovered country. J Hepatol 61(1):155–163CrossRefPubMed
Metadata
Title
Abdominal infection reveals a rare disease
Authors
Clara Benedetta Conti
Mirella Fraquelli
Dario Conte
Publication date
01-06-2018
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 4/2018
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-017-1737-2

Other articles of this Issue 4/2018

Internal and Emergency Medicine 4/2018 Go to the issue